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 2 
Plasmodium parasites, the causative agents of malaria, have evolved a unique cell 30 
division cycle in the clinically relevant asexual blood-stage of infection1. DNA 31 
replication commences approximately halfway through the intracellular development 32 
following invasion and parasite growth. The schizont stage is associated with multiple 33 
rounds of DNA replication and nuclear division without cytokinesis resulting in a 34 
multinucleated cell. Nuclei divide asynchronously through schizogony, with only the 35 
final round of DNA replication and segregation being synchronous and coordinated 36 
with daughter cell assembly2,3. However, the control mechanisms for this divergent 37 
mode of replication are unknown. Here we show that the Plasmodium-specific kinase 38 
PfCRK4 is a key cell cycle regulator that orchestrates the multiple rounds of DNA 39 
replication throughout schizogony in P. falciparum. PfCRK4 depletion led to a complete 40 
block in nuclear division and profoundly inhibited DNA replication. Quantitative 41 
phosphoproteomic profiling identified a set of PfCRK4-regulated phosphoproteins with 42 
greatest functional similarity to CDK2 substrates, particularly proteins involved in 43 
origin of replication firing. PfCRK4 was required for the initial and subsequent rounds 44 
of DNA replication during schizogony, and in addition was essential for development in 45 
the mosquito vector. Our results identified an essential S phase promoting factor of the 46 
unconventional P. falciparum cell cycle. PfCRK4 is required for both a prolonged 47 
period of the intraerythrocytic blood-stage of malaria infection, as well as for 48 
transmission, revealing a broad window for PfCRK4-targeted chemotherapeutics. 49 
Malaria parasites proliferate through schizogony in the blood-stage of infection: a 50 
series of rapid rounds of DNA replication and nuclear division produces a syncytial cell with 51 
approximately 20 nuclei. In contrast to the synchronous nuclear division observed in other 52 
multinucleated cells, such as the early Drosophila embryo4, P. falciparum nuclei divide 53 
asynchronously during the blood-stage despite sharing the same cytoplasm2,3, suggesting that 54 
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cell cycle progression is not governed by diffusible cytoplasmic factors. Knockout screens 55 
have identified non-essential blood-stage Plasmodium kinases, and suggested those that could 56 
be essential for the regulation of schizogony5,6. The molecular mechanisms regulating this 57 
diverged mode of replication are largely unknown yet the recent development of conditional 58 
gene expression technologies now allows to unequivocally demonstrate gene essentiality in 59 
P. falciparum7-9. 60 
To directly identify critical regulators of schizogony and simultaneously determine 61 
protein function, we adopted the destabilization domain (DD) conditional knockdown 62 
approach7,10,11. We generated endogenous DD fusions of 23 schizont-stage kinases in the P. 63 
falciparum D10 strain and screened for vulnerability to destabilization by DD (Fig. 1a, b, 64 
Supplementary Information Fig. 1a). Using this approach, we found that two kinases, the 65 
cGMP-dependent protein kinase (PfPKG) and the cdc2-related protein kinase 4 (PfCRK4), 66 
had profound proliferation defects in absence of Shield-1 and showed dose-dependency (Fig. 67 
1c, Supplementary Information Fig. 1b, c). Chemical inhibition of PfPKG has previously 68 
established its essential role in parasite egress from erythrocytes at the end of schizogony12,13, 69 
now confirmed by conditional destabilization.  70 
As previously observed14,15, we found little correlation between the level of protein 71 
knockdown and the ability to reveal essentiality of other kinases previously thought to be 72 
essential6 using the DD approach (Fig. 1d, Supplementary Information Fig. 1d, 9c, d). This 73 
could be due to insufficient destabilization of these proteins or because they are required at 74 
inherently different levels for asexual proliferation. 75 
The biological function of PfCRK4 is unknown and we confirmed its essentiality in a 76 
different parental line, P. falciparum P2G1216, which also produces gametocytes 77 
(Supplementary Information Fig. 2). PfCRK4 is a member of an Apicomplexa-specific kinase 78 
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subfamily related to cyclin-dependent kinases (CDK) (Supplementary Information Fig. 3, 79 
Supplementary Data table 1)17,18. In many organisms CDKs in complex with cyclins regulate 80 
key steps of the cell cycle and other cellular functions19,20. Compared to human CDK2, the 81 
kinase domain of PfCRK4 possesses multiple sequence inserts of unknown function (Fig. 2a, 82 
Supplementary Information Fig. 4). 83 
PfCRK4 is localized to the nucleus of late trophozoites and schizonts, with the signal 84 
greatly diminished in segmented schizonts that had undergone cytokinesis (Fig. 2b). 85 
Following conditional depletion of PfCRK4 (Fig. 1d) parasites arrested at the trophozoite-to-86 
schizont transition (Fig. 2c). At ≥40 hours post invasion (hpi), parasites [+] Shield-1 (i.e., 87 
wild type PfCRK4 levels) segmented into daughter cells, containing nuclei and rhoptries 88 
(apical organelles required for merozoite invasion), which are characteristic of mature 89 
schizonts (Fig. 2d, top). In contrast, parasites cultured [–] Shield-1 (i.e., PfCRK4 is depleted) 90 
showed no nuclear division or apical organelle biogenesis (Fig. 2d, bottom, Supplementary 91 
Information Fig. 5a).  92 
Analysis of nuclei stained with fluorescent DNA-specific dyes confirmed that the 93 
nuclei did not divide and revealed a substantially distorted nuclear morphology (Fig. 2e, 94 
Supplementary Information Fig. 5b). Hemispindle structures were evident in PfCRK4-95 
depleted cells (Fig. 2f; Supplementary Information Fig. 5c, d); however, they were greatly 96 
enlarged relative to spindles in wild type parasites and might account for the nuclear 97 
distortion. Concordantly, division of the centriolar plaque3,21, the parasite’s microtubule 98 
organizing centre, was diminished (Fig. 2g). To ascertain whether PfCRK4 affects DNA 99 
replication, we quantified the parasite’s DNA content by flow cytometry22,23. While in wild 100 
type parasites DNA replication commences at 29-32 hpi, i.e., parasites with C-values >1 101 
appear, we found DNA replication to be profoundly inhibited in PfCRK4-depleted parasites 102 
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(Fig. 2h). In contrast, the development of the mitochondria and apicoplast organelles was 103 
unaffected following depletion of PfCRK4 (Supplementary Information Fig. 5e, f). The 104 
PfCRK4-dependent block was completely reversible up to 38 hpi by addition of Shield-1. 105 
However, reversion at 48 hpi led to very poor recovery (Fig. 2i), identifying a window within 106 
which PfCRK4 depletion is cytostatic before becoming cytotoxic. 107 
To elucidate processes regulated by PfCRK4, we assessed changes in the 108 
phosphoproteome of PfCRK4-depleted parasites at two time points (Fig. 3a): at 29 hpi, when 109 
PfCRK4 is already expressed at the onset of DNA replication (Fig. 2b, h), and also at 37 hpi, 110 
where in wild type parasites DNA replication is evident and when the PfCRK4-dependent 111 
arrest was still reversible (Fig. 2h, i) (Supplementary Information Fig. 6; Supplementary Data 112 
table 2-5). Large changes occur in the phosphoproteome at 29 hpi indicating that PfCRK4 is 113 
active when the first round of DNA replication commences (Fig. 2h). We used k-means 114 
clustering to identify the phosphosites most affected by the PfCRK4 depletion, which showed 115 
a reduction of about 2-fold (Supplementary Information Fig. 6b). Applying a threshold based 116 
on a ≥2-fold decrease in phosphorylation and p-values <0.05, we identified 220 proteins (80 117 
from 29 hpi, 215 from 37 hpi with 75 proteins shared), suggesting that these belong to a 118 
PfCRK4-regulated set of phosphoproteins (Fig. 3b, Supplementary Data table 4). Western 119 
blot analysis confirmed differential phosphorylation of histone H3 (serine 28) in a different 120 
genetic background (Supplementary Information Fig. 6c). The most enriched phosphorylation 121 
motif within these proteins was a previously undescribed SΦxK motif (Φ, hydrophobic; x, 122 
any amino acid), with S being phosphorylated. The canonical CDK motif S/TP24,25, with S or 123 
T phosphorylated, was also enriched (Supplementary Information Fig. 6d, e).  124 
To examine the functional significance of the PfCRK4-regulated set of proteins, we 125 
used gene ontology (GO) term enrichment analysis (Fig. 3c). The most enriched biological 126 
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process GO term was ‘DNA replication’, and ‘nucleus’ was the most enriched cellular 127 
component GO term. Strikingly, six of the seven identifiable P. falciparum homologues (or 128 
subunits thereof) of the 16 Saccharomyces cerevisiae factors required for origin licensing and 129 
firing in vitro26 showed reduced phosphorylation in PfCRK4 depleted parasites (Fig. 3c, box; 130 
Supplementary Information Fig. 6f, Supplementary Data table 3, 4). GO terms of proteins 131 
with a ≥2-fold increase in phosphorylation (p-value <0.05) were enriched for biosynthetic 132 
and intracellular transport processes at 37 hpi, perhaps indicating secondary effects; however, 133 
no statistically significant enrichment was observed at 29 hpi (Supplementary Information 134 
Fig. 6g). 135 
We next compared the GO terms of the PfCRK4-regulated set with GO terms of other 136 
available kinase substrate sets–one S. cerevisiae kinase27 and 19 human kinases28 137 
(www.phosphosite.org)–each with ≥30 confirmed substrates (Fig. 3d). The substrate set of 138 
human CDK2, a major S phase promoting factor, showed the highest percentage of shared 139 
annotations, suggesting that PfCRK4 acts in a related fashion to promote S phase in P. 140 
falciparum.   141 
PfCRK4 expression increases through schizogony (Fig. 2b) and its transcripts peak 142 
the latest of all putative Plasmodium CDK-like kinases29. We therefore hypothesized that 143 
PfCRK4 is crucial for all rounds of DNA replication seen in schizogony. When we depleted 144 
PfCRK4 at points later in schizogony, we detected no further increase in DNA content (Fig. 145 
4a), premature termination of nuclear division (Fig. 4b), and parasites failed to proliferate 146 
(Fig. 4c). Thus demonstrating that PfCRK4 function is critical throughout schizogony. 147 
To determine a role for PfCRK4 in other life cycle stages, we used the P2G12-148 
PfCRK4-HA-DD line that produces high levels of gametocytes to analyse PfCRK4 function 149 
during parasite transmission to the Anopheles gambiae mosquito vector. While we detected 150 
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nuclear expression of PfCRK4 in gametocytes (Fig. 4d, Supplementary Information Fig. 7a), 151 
depletion during the latter portion of gametocyte development (i.e. from day 6 to 16 post-152 
induction) had no effect on gametocytemia nor on the male-to-female gametocyte ratio 153 
(Supplementary Information Table 1). PfCRK4 depletion also did not impair exflagellation 154 
(Supplementary Information Fig. 7b, c, d). We observed a reduced PfCRK4 signal in 155 
ookinetes (Supplementary Information Fig. 7e), and the numbers of oocysts on An. gambiae 156 
female midguts was greatly diminished upon PfCRK4 depletion (Fig. 4e, Supplementary 157 
Information Fig. 8). Oocysts derived from gametocyte cultures in the presence of PfCRK4 158 
showed multiple nuclei, well-expanded organelles, and a well-developed capsule (Fig. 4f, 159 
top). In contrast, infections with PfCRK4-depleted gametocytes resulted in necrotic parasites 160 
reminiscent of dead ookinetes, the motile zygote of Plasmodium parasites (Fig. 4f, bottom; 161 
Supplementary Information Fig. 8). This indicates that PfCRK4 is required at some point 162 
during ookinete formation and early oocyst development, and likely plays a role during DNA 163 
replication in zygotes. 164 
Our data provide evidence that PfCRK4 is an essential protein kinase promoting S 165 
phase through the initiation of multiple rounds of DNA replication during schizogony. While 166 
phosphorylation is likely important for the regulation of PfCRK4 (Supplementary 167 
Information Fig. 3b, 4a), a potential cyclin-dependence is in question as the cyclin binding 168 
domain is poorly conserved (Supplementary Information Fig. 4a)17. Interestingly, 169 
homologues of Group I cyclins are not found in the Plasmodium genome, including cyclin E, 170 
which is critical for G1 to S transition in other systems30. Interventions targeting PfCRK4 171 
function would be efficacious throughout the extended period of schizogony in the clinically 172 
relevant blood-stage, as well as at the transmission stages, which taken together are attractive 173 
features for future drug development.  174 
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Methods 207 
Reagents and oligonucleotide primers. We purchased chemicals from Sigma-Aldrich 208 
(unless otherwise noted), primers Integrated DNA Technologies (sequences are available 209 
upon request), and restriction enzymes from New England Biolabs. 210 
Construction of plasmids. The terminal 1-2 kb of PKB (PF3D7_1246900), TLK4 211 
(PF3D7_0623800), and PKG (PF3D7_1436600) were sub-cloned into the 3’ replacement 212 
vector pJDD417, generating HA-DD single crossover tagging plasmids. The terminal ~1 kb 213 
of PF3D7_0420100 was amplified using an extended reverse primer, introducing two 214 
additional HA-tags. Cloning into pJDD41 resulted in a 3xHA-DD single crossover tagging 215 
plasmid. All other targeting fragments were sub-cloned into this 3xHA-DD plasmid 216 
(sequences available upon request). 217 
Parasite culture, transfection and synchronization. P. falciparum D10 was obtained from 218 
the Walter and Eliza Hall Institute (Melbourne, Australia). P. falciparum P2G12 (clone of 219 
3D7) was obtained from Harvard T.H. Chan School of Public Health (Boston, USA). 220 
Parasites were cultured as previously described in RPMI-1640 media supplemented with 221 
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0.5% Albumax-II (Invitrogen), 50 mg / l hypoxanthine, 0.21% Sodium Bicarbonate, and 25 222 
mM HEPES (EMD Biosciences)31. Human O+ erythrocytes (Research Blood Components) 223 
were diluted to 2-4% haematocrit. Transgenic parasites were generated by electroporation of 224 
synchronized ring-stage parasites as previously described32. Single homologous 225 
recombination events were selected in presence of 500 nM Shield-1 by cycling on and off 226 
WR99210 (Jacobus Pharmaceutical Company) and cloned by limiting dilution. Parasites 227 
were synchronized by a combination of heparin and sorbitol treatments as previously 228 
described33. Unless otherwise noted, DD-tagged parasites were cultured in 250 nM Shield-1. 229 
When desired, Shield-1 was removed by triple washes with excess of RPMI. 230 
Southern blot analysis. Genomic DNA was harvested with QIAamp Blood Mini Kit 231 
(Qiagen) and digested with the enzymes indicated in Supplementary Fig. 1a, resolved on 232 
0.8% agarose gels, transferred to GeneScreen Plus (Perkin Elmer), and hybridized with 233 
specific radiolabeled probes. 234 
May-Grünwald-Giemsa staining and imaging of blood-stage parasites. Air-dried thin-235 
smear blood films were fixed and stained according to manufacturers instructions and imaged 236 
on a Zeiss AxioCam microscope equipped with a 100X oil-immersion objective. Raw images 237 
were analysed using ImageJ34. 238 
Dose response experiments. Dose response curves were generated as previously described 239 
using SYBR® Green I35. In brief, triplicate 2-fold Shield-1 dilution series were set up in 100 240 
µl parasite cultures (0.075% parasitemia in 2% haematocrit). After two cycles, parasites were 241 
lysed with 20 µl of 6x SYBR® green I lysis buffer (0.16% saponin; 20 mM Tris-HCl, 5 mM 242 
EDTA, 1.6% Triton X 100, pH 7.4), supplemented with 1:1.000 SYBR® green I (from 243 
10.000x stock, Thermo Fisher). Fluorescence intensity was measured on a SpectraMax M5 244 
plate reader (Molecular Devices). 245 
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Conditional destabilization screen of schizont-stage kinases. We used the relative log10 246 
parasite multiplication rate (PMR) [–] over [+] Shield-1 as a measure of the effect of 247 
conditional destabilization of schizont-stage kinases. Synchronized ring-stage parasites of all 248 
P. falciparum kinase-DD fusion lines were seeded in triplicate at 0.05% parasitemia, 0.5% 249 
haematocrit [+] or [–] Shield-1. Parasitemia was monitored by flow cytometry (see below) 250 
and expressed as log10. Linear regression analysis (Prism, GraphPad) allowed calculating the 251 
PMR. The effect of protein knockdown ([–] Shield-1) relative to [+] Shield-1 was plotted as 252 
log10 PMR [–] Shield-1 over log10 PMR [+] Shield-1. The error (standard deviation) for  253 
𝑓 =
𝐴
𝐵
 254 
was propagated as follows:  255 
𝑠𝑓 = |𝑓|√(
𝑠𝐴
𝐴
)
2
+ (
𝑠𝐵
𝐵
)
2
 256 
Where A is the log10 PMR [–] Shield-1, B is the log10 PMR [+] Shield-1 and sA and sB are the 257 
sample standard deviations in A and B, respectively36. 258 
Parasitemia quantification by flow cytometry. Parasitized erythrocytes were fixed as 259 
previously described37, stained with 1:2.000 SYBR® green I (Life Technologies) in PBS, and 260 
analysed on a Miltenyi MACSQuant® flow cytometer. Data were analysed using FlowJo 261 
(Tree Star) and Prism (GraphPad) software. 262 
Immunoblot analysis. Synchronized parasites were harvested and uninfected erythrocytes 263 
were removed using 0.05% saponin in PBS plus 1x cOmpleteTM protease inhibitor cocktail 264 
(Roche). Upon washes, parasites were lysed in Laemmli sample buffer and proteins were 265 
resolved by SDS-PAGE, transferred to nitrocellulose, and probed with the following primary 266 
antibodies: anti-HA (1:1.000; Roche; clone 3F10), anti-Pflactate dehydrogenase (LDH) 267 
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(1:2.000; gift of Michael T. Makler), anti-histone H3 (1:1.000; Abcam; ab1791), anti-pS28 268 
histone H3 (1:1.000; Abcam; ab5169), anti-Pfaldolase (1:40.000, Abcam; ab38905). Signal 269 
intensities were quantitated using ImagJ. 270 
Gametocyte assays and An. gambiae infections. Gametocyte cultures were seeded at 0.5% 271 
parasitemia in 5 ml RPMI with 10% serum, 4% haematocrit, and 1 µM Shield-1 and kept in a 272 
candle jar at 37 °C. From day six onwards parasites were cultured [+] and [–] Shield-1. 273 
Estimates for the various stages and sexes were determined from a Giemsa-stained thin-274 
smear blood film. On days 15 to 18 of culture, parasites were harvested and male gametocyte 275 
exflagellation was assessed by microscopy. For the infection of An. gambiae KEELE strain 276 
females, cultures were washed and gametocytemia was adjusted to 0.3% in normal human 277 
serum with 45% haematocrit. Subsequently, females were infected in a Standard Membrane 278 
Feeding Assay as previously described38. 279 
Oocyst quantification. Midguts from infected An. gambiae females were dissected on days 7 280 
or 8 post blood-feeding and subsequently the number of oocysts were enumerated following 281 
0.1% mercurochrome staining and analysis by light microscopy (20X objective).  282 
DNA content analysis. The DNA-content of parasites was determined by flow cytometry. 283 
Parasitized erythrocytes were fixed in 4% paraformaldehyde and 0.0075% glutaraldehyde for 284 
45 min at room temperature37. To reduce RNA-derived background signal cells were 285 
permeabilized with 0.1% Triton X-100, treated with 0.3 mg / ml RNase A for 20’ at 37 °C, 286 
and subsequently washed. Cells were stained with 1:2.000 SYBR® green I (Life 287 
Technologies) in PBS, washed, and analysed on a Miltenyi MACSQuant® flow cytometer. 288 
Data were analysed using FlowJo (Tree Star), Excel (Microsoft), and Prism (GraphPad) 289 
software. Second cycle ring-stage parasites were omitted for DNA content analysis of 48 hpi 290 
schizont-stage parasites. 291 
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Immunofluorescence assays. Immunofluorescence assays of blood-stage parasites was done 292 
as previously described37,39. In brief, parasitized erythrocytes were air-dried, methanol-293 
fixed39, and analysed using rat anti-HA (1:100, Roche, clone 3F10), mouse anti-centrin 294 
(1:500, Millipore, clone 20H5), mouse anti--tubulin (1:2.000, Sigma-Aldrich, clone B-5-1-295 
2), rabbit anti-GAP45 (1:2.000, gift of Julian C. Rayner), or rabbit anti-PfEBA175 (1:500, 296 
Malaria Research and Reference Reagent Resource Center, R3347) antibodies. Alternatively, 297 
parasites were fixed in solution37 for 20 min at room temperature, immobilized on poly-L-298 
lysine coated cover slips (Corning®), and analysed using mouse anti--tubulin (1:2.000, 299 
Sigma-Aldrich, clone B-5-1-2) or rabbit anti-P. falciparum acyl carrier protein40 (1:500, gift 300 
of Sean T. Prigge) antibodies. Primary antibodies were detected using Alexa Fluor® 301 
conjugated secondary antibodies (1:2.000, Thermo Fisher Scientific). Cells were mounted 302 
with DAPI Fluoromount-G® (SouthernBiotech) or cells were stained with Hoechst 33342 303 
(Thermo Fisher Scientific) and mounted Fluoromount-G® (SouthernBiotech), imaged on a 304 
Nikon Eclipse TE300 microscope equipped with a Hamamatsu C10600 Orca R2 digital 305 
camera, and analysed employing ImageJ software. 306 
For immunofluorescence analysis of exflagellation, mature gametocytes were 307 
resuspended in RPMI-1640 media supplemented with 20% human serum (AB+), 50 mg / l 308 
hypoxanthine, 0.21% Sodium Bicarbonate, 25 mM HEPES (EMD Biosciences), and 50 µM 309 
xanthurenic acid at room temperature and pH 8 to induce exflagellation41. Following 20 min 310 
incubation at room temperature, cells were washed, spotted on a glass slide, air-dried, 311 
methanol-fixed, and further processed as described above. 312 
For immunofluorescence analysis of ookinetes, female An. gambiae mosquitoes were 313 
fed with late stage PfCRK4-HA-DD gametocyte cultures, which were maintained [+] and [–] 314 
Shield-1 from day 6 post-induction. Approximately 24 hours post-feeding, the blood bolus 315 
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from the mosquito midgut lumen was isolated. Bolus material was spotted on glass slides and 316 
air-dried preceding immunofluorescence analysis. 317 
Immunofluorescence analysis of P. falciparum late midgut oocysts was done as 318 
previously described42. In brief, dissected midguts were fixed in 4% paraformaldehyde for 1h 319 
at room temperature, washed, and permeabilized, and blocked using 0.2% Triton X-100 in 320 
1% bovine serum albumin in PBS. Midgut oocysts were analysed using a mouse anti-321 
circumsporozoite (CS) protein antibody (15 µg/ml, gift of Photini Sinnis), an Alexa Flour® 322 
594 secondary antibody (1:1.000), and DAPI nuclear stain, mounted on a glass slide in 10% 323 
glycerol in PBS, and imaged on a Nikon Eclipse 90i microscope. Raw images were analysed 324 
using Volocity software (Perkin-Elmer).  325 
JC-1 staining of P. falciparum mitochondria. Parasite mitochondria were stained with the 326 
cationic mitochondrial membrane potential sensor JC-1 (Life Technologies) as previously 327 
described43. In brief, 2 µM JC-1 in 37 °C warm RPMI was filtered using an Acrodisc® 328 
Syringe Filter (0.2 µm HT Tuffryn® Membrane, Pall) to removed preformed JC-1 329 
aggregates. Parasites were incubated with JC-1 containing media for 20 min at 37 °C, 330 
washed, and imaged immediately on a Nikon Eclipse TE300 microscope with equipped a 331 
Hamamatsu C10600 Orca R2 digital camera and analysed employing ImageJ software. 332 
Electron microscopy. Synchronized blood-stage parasites were isolated by magnetic affinity 333 
purification using a MACS LS column (Miltenyi Biotec), adjusted to ~50% parasitemia with 334 
uninfected erythrocytes, and resuspended in 200 µl 3% BSA in PBS. Cells were fixed for 1h 335 
at room temperature with an equal volume of 2.5% paraformaldehyde, 5.0% glutaraldehyde, 336 
and 0.06% picric acid in 0.2 M cacodylate buffer. Cells were washed in cacodylate buffer, 337 
post-fixed for 1 h with 1% osmium tetroxide (OsO4), 1.5% potassium ferrocyanide 338 
(KFeCN6), and washed in H2O. Following 1h incubation in 1% aqueous uranyl acetate 339 
solution, samples were washed in H2O and subsequently dehydrated in grades of alcohol. The 340 
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samples were placed in propyleneoxide for 1 h and infiltrated in a 1:1 mixture of 341 
propyleneoxide and TAAB Epon (Marivac) over night. Samples were embedded in TAAB 342 
Epon and polymerized at 60 °C for 48 h. Ultrathin sections from a Reichert Ultracut-S 343 
microtome were mounted on copper grids and stained with lead citrate. Samples were imaged 344 
on a TecnaiG2 Spirit BioTWIN with an AMT 2k CCD camera under 80 kV. 345 
For P. falciparum oocyst thin-section transmission electron microscopy, infected 346 
midguts were fixed at day 7 post infection in 2.5% glutaraldehyde (Electron Microscopy 347 
Sciences) and processed as described44. Stained sections were examined with a Philips 348 
CM120 EM under 80 kV. 349 
Phosphoproteomic profiling. Cell culture and harvest. Synchronized D10-PfCRK4-HA-DD 350 
parasites were cultured for 29 or 37 hours post invasion (hpi) [+] or [–] Shield-1. At 29 hpi 351 
duplicate samples were harvested, at 37 hpi triplicate samples were harvested for each [+] 352 
and [–] Shield-1. For each of the ten samples ~1.25 X 109 parasites were isolated and 353 
uninfected erythrocytes were removed using saponin buffer (0.05% saponin in PBS plus 1x 354 
PhosSTOP (Roche), 1x cOmpleteTM protease inhibitor cocktail (Roche), and 1 mM 355 
phenylmethanesulfonyl fluoride (PMSF)). Subsequently, cells were washed in saponin buffer 356 
to further remove erythrocytes and erythrocyte debris, followed by washes with PBS plus 1x 357 
PhosSTOP, 1x cOmpleteTM protease inhibitor cocktail, and 1 mM PMSF.  358 
Cell lysis and protein digestion. Lysates were prepared as previously described45,46. In 359 
brief, cells were lysed in 8 M urea, 100 mM sodium chloride, 25 mM TRIS pH 8 plus 1x 360 
PhosSTOP, 1x cOmpleteTM protease inhibitor cocktail, and 1 mM PMSF in PBS. The protein 361 
concentration was estimated in the Bio-Rad Protein Assay (Bio-Rad). Disulfide bonds were 362 
reduced with 5 mM tris(2-chloroethyl) phosphate (TCEP) for 30 min at 37 °C. Cysteines 363 
were alkylated with 15 mM iodoacetamide for 30 min at room temperature in the dark, 364 
followed by incubation with 5 mM DTT for 15 min at room temperature in the dark to 365 
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quench excess of iodoacetamide.  366 
Chloroform-methanol precipitated proteins47 were resuspended in 8 M urea, 50 mM 367 
HEPES pH 8.5 and subsequently diluted to 1 M urea 50 mM HEPES pH 8.5 for digestion 368 
with LysC protease (1:100 protease-to-protein ratio, 3 h at 37 °C) before addition of trypsin 369 
(1:100 protease-to-protein ratio) and continued digest overnight at 37 °C. The reaction was 370 
quenched with 1% formic acid, subjected to C18 solid phase extraction (Sep-Pak, Waters), 371 
followed by vacuum-centrifugation. 372 
Isobaric labelling with tandem mass tags (TMT). Peptides (200 µg) from each sample 373 
were dissolved in 100 mM HEPES pH 8.5. Labelling with TMT reagents (Thermo Fisher 374 
Scientific) was done according the manufactures instructions and as previously described48. 375 
The TMT-labelled samples were combined at a 1:1 ratio across all samples, vacuum 376 
centrifuged to near dryness, and subjected to C18 solid phase extraction (Sep-Pak, Waters). 377 
Phosphopeptide enrichment. Peptides were resuspended in 100 mM HEPES pH 8.5 378 
and phosphopeptides were enriched using Titanosphere TiO2 5 µm particles (GL 379 
Biosciences) as previously described46,48,49. The flow-through was kept for proteome 380 
analysis. Enriched TMT-labelled phosphopeptides and peptides were dried via vacuum 381 
centrifugation. 382 
Off-line basic pH reversed-phase (BPRP) fractionation. For protein level analysis, we 383 
fractionated the pooled TMT-labelled peptide sample via BPRP HPLC as previously 384 
described48,50. Fractions were desalted, dried, and reconstituted in 5% acetonitrile, 5% formic 385 
acid for LC-MS/MS processing. 386 
For phosphopeptide analysis, we used the Pierce Off-line basic pH reversed-phase 387 
(BPRP) fractionation kit (Thermo Scientific). Fractions collected included organic buffer 388 
bumps with 5, 7.5, 10, 12.5, 15, 17.5, 20, 50, and 70% acetonitrile, in addition to the wash 389 
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and flow through fractions. These fractions were vacuum-centrifuged to near dryness, 390 
desalted via StageTip, dried, and reconstituted in 5% acetonitrile, 5% formic acid for LC-391 
MS/MS processing. 392 
Liquid chromatography and tandem mass spectrometry. Data were collected using an 393 
Orbitrap Fusion mass spectrometer (Thermo Fisher Scientific) coupled to a Proxeon EASY-394 
nLC II liquid chromatography (LC) pump (Thermo Fisher Scientific). Peptides were 395 
fractionated on a 75 µm inner diameter micro capillary column packed with ~0.5 cm of 396 
Magic C4 resin (5 µm, 100 Å, Michrom Bioresources) followed by ~35 cm of GP-18 resin 397 
(1.8 µm, 200 Å, Sepax). For each analysis, we loaded ~1 μg onto the column. 398 
For total proteome analysis, peptides were separated using a 180 min gradient of 6-399 
23% acetonitrile in 0.125% formic acid (flow rate: ~600 nl / min). Each analysis used the 400 
multi-notch MS3-based TMT method51. The scan sequence began with an MS1 spectrum 401 
(Orbitrap analysis; resolution 120.000; mass range 400-1,400 m/z; automatic gain control 402 
(AGC) target 2.0 X 105; maximum injection time 100 ms). Precursors for MS2/MS3 analysis 403 
were selected using a TopSpeed 2 seconds method. MS2 analysis consisted of collision-404 
induced dissociation (quadrupole ion trap analysis; AGC 4 X 103; normalized collision 405 
energy (NCE) 35; maximum injection time 150 ms). Following acquisition of each MS2 406 
spectrum, we collected an MS3 spectrum using a recently described method in which 407 
multiple MS2 fragment ions were captured in the MS3 precursor population using isolation 408 
waveforms with multiple frequency notches51. MS3 precursors were fragmented by high-409 
energy collision-induced dissociation (HCD) and analysed (NCE 55; AGC 5 X 104; 410 
maximum injection time 150 ms, resolution was 60.000 at 200 Th).  411 
For phosphoproteome analysis, peptides were separated using a 120 min gradient of 412 
3-23% acetonitrile in 0.125% formic acid (flow rate: ~575 nl / min). Each analysis used the 413 
multi-notch MS3-based TMT method51. The scan sequence was identical to the proteome 414 
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scan, except the maximum injection time was 200 ms for MS2 analysis and 250 ms for MS3 415 
analysis. 416 
Initial mass spectrometry data analysis. Mass spectra were processed using a 417 
SEQUEST-based in-house software pipeline52. Spectra were converted to mzXML using a 418 
modified version of ReAdW.exe. Database searching included all entries from a combined 419 
Uniprot human and Plasmodium database (February, 2015). This database was concatenated 420 
with one composed of all protein sequences in the reversed order. Total protein level analysis 421 
searches were performed using a 50 ppm precursor ion tolerance, product ion tolerance was 422 
set to 0.9 Da. These wide mass tolerance windows were chosen to maximize sensitivity in 423 
conjunction with SEQUEST searches and linear discriminant analysis52,53. TMT tags on 424 
lysine residues and peptide N termini (+229.163 Da) and carbamidomethylation of cysteine 425 
residues (+57.021 Da) were set as static modifications, while oxidation of methionine 426 
residues (+15.995 Da) was set as a variable modification for both total proteome and 427 
phosphoproteome datasets. For phosphoprotein analysis, +79.966 Da was set as a variable 428 
modification on serine, threonine, and tyrosine residues. 429 
Peptide-spectral matches (PSMs) were adjusted to a 1% false discovery rate 430 
(FDR)54,55. PSM filtering used a linear discriminant analysis as previously described52, while 431 
considering the following parameters: XCorr, ΔCn, missed cleavages, peptide length, charge 432 
state, and precursor mass accuracy. For the phosphorylation dataset, site localization was 433 
evaluated via AScore53. For TMT-based reporter ion quantitation, we extracted the summed 434 
signal-to-noise (S/N) ratio for each TMT channel and found the closest matching centroid to 435 
the expected mass of the TMT reporter ion. 436 
The search space for each reporter ion was limited to a range of 0.003 Th to prevent 437 
overlap between the isobaric reporter ions. For protein-level comparisons, PSMs were 438 
identified, quantified, collapsed to a 1% peptide false discovery rate (FDR), and further 439 
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collapsed to a final protein-level FDR of 1%. Protein assembly was guided by principles of 440 
parsimony to produce the smallest set of proteins necessary to account for observed peptides. 441 
Proteins were quantified by summing reporter ion counts across all matching PSMs 442 
using in-house software, as previously described52. Poor quality PSMs, MS3 spectra with >8 443 
TMT reporter ion channels missing, MS3 spectra with TMT reporter summed signal-to-noise 444 
ratio <100, or no MS3 spectra were excluded from quantitation51. Protein quantitation values 445 
were exported for further analysis in Microsoft Excel or SAS JMP. Each reporter ion channel 446 
was summed across all quantified proteins and normalized assuming equal protein loading of 447 
all 10 samples. 448 
Evolutionary relationship of PfCRK4. Protein kinase amino acid sequences from the 449 
cyclin-dependent kinase (CDK) families of apicomplexans and model organism and non-450 
CDK out-group kinases were chosen for comparison with PfCRK4 (Supplementary Data 451 
table 1). Kinase domain sequences were trimmed, aligned using MUSCLE56 and analysed 452 
using RAxML57. 453 
Domain drawings of PfCRK4 and its orthologues in Plasmodium spp. Domain boundaries 454 
were identified by searching sequences against Pfam58 using the HMMER package59. 455 
Domains were illustrated using Protdraw (http://sourceforge.net/projects/protdraw/). 456 
Homology modelling of PfCRK4. The protein kinase domain of PfCRK4 was modelled 457 
using the co-crystal structure of the human CDK2-Cyclin A-substrate peptide complex 458 
(1QMZ.pdb)25. We used this structure as a template in order to model PfCRK4 in a 459 
potentially active form. The kinase domains of the target and query sequences were aligned 460 
using MUSCLE56 followed by manual review and adjustment. Homology models were made 461 
using MODELLER 9.1560. Structural alignments were reviewed and adjusted using 462 
Chimera61. 463 
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Identification of conditionally related clusters in proteomic and phosphoproteomic data. 464 
The total sum signal-to-noise values of peptides collapsed into proteins are given in 465 
Supplementary Data table 3. For phosphopeptides values are given in Supplementary Data 466 
table 4. Contaminants and false positives were removed, and values for each channel were 467 
normalized by the column sum. Values were placed on a scale of 0 - 1 by dividing by the 468 
maximum value for the protein or phosphopeptide. Scaling was done for all channels at once 469 
and separately for experiments at 29 hpi and 37 hpi. Phosphopeptides for which the total sum 470 
signal-to-noise sum ≤100 were not included in clustering analysis, and the total sum signal-471 
to-noise values were adjusted to reflect protein levels from the proteome analysis. K-means 472 
clustering62 was done using R (http://cran.r-project.org/) with the Hartigan-Wong method 473 
using 1,000 starting configurations and 10,000 iterations. Clustering results, log2-fold 474 
changes, and –log10 p-values (Student’s t-test) are included in Supplementary Data tables 3 475 
and 4. 476 
Gene orthology relationships. Relationships between P. falciparum proteins and 477 
Saccharomyces cerevisiae orthologues for Figure 3F Box (Supplementary Data table 3) were 478 
investigated using a downloaded version of the OrthoMCL database, version 563. A 479 
comprehensive orthology analysis is provided in Supplementary Data table 6.  480 
Functional annotation and enrichment analysis. The functional enrichment of sets of 481 
proteins with phosphopeptides most reduced in knockdown experiments at 29 hpi and 37 hpi 482 
was assessed using Ontologizer64. Gene association files containing gene ontology (GO) 483 
terms for Plasmodium falciparum, Saccharomyces cerevisiae, and Homo sapiens were from 484 
http://www.geneontology.org/gene-associations65 downloaded on May 21, 2015. To generate 485 
comparative heat maps of GO terms for both time points we selected the most specific terms, 486 
i.e. those without children, which we refer to as “tips” for convenience. Enrichment p-values 487 
were included in the heat map if they were present at either time point; p-values for non-tip 488 
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terms were included if the term was a tip at the other time point. GO term annotations of the 489 
proteins detected in this study are given in Supplementary Data table 3 and defined in 490 
Supplementary Data table 7. 491 
Functional comparison of the PfCRK4-regulated set of phosphoproteins. The functional 492 
similarity between PfCRK4 and other protein kinases was assessed by comparing GO terms 493 
of the PfCRK4-regulated set with GO terms of reference kinase substrate sets. Reference 494 
human kinase substrate sets were obtained from PhosphoSitePlus 495 
(http://www.phosphosite.org/staticDownloads.do)28 on May 4, 2015, the substrate set from 496 
Saccharomyces cerevisiae (Sc) cdc28 came from27. Reference kinases with less than 30 497 
identified substrates were omitted in the analysis. Functional enrichment was assessed as 498 
described above. To calculate the relatedness of the substrate sets of kinases with PfCRK4, 499 
the number of terms in the intersect of the set of significantly enriched functions from the 500 
PfCRK4-regulated set and the substrate set from the reference kinases was divided by the 501 
number of significant functional terms in the substrate set from the reference kinase. 502 
Identification and enrichment analysis of phosphorylation motifs. Alignments of 503 
phospho-peptides with reduced abundance in the absence of Shield-1 were manually 504 
inspected. The two motifs discernable in this set may be retrieved from tab-delimited tables 505 
of triskaidekapeptides by the regular expressions66: \t[A-Z]{6}[ST][IVLFMWA].[RKH] (the 506 
SϕxK motif; ϕ, hydrophobic amino acid; x, any amino acid) and \t[A-Z]{6}[ST]P (the S/TP 507 
motif). The set of phosphopeptides detected in this study (Supplementary Data table 4) was 508 
searched with these regular expressions and the percentage peptides comprised of these 509 
motifs was calculated. Phosphopeptides containing SϕxK and S/TP motifs are identified in 510 
Supplementary Data table 4. Sequence logos were made from alignments of phosphopeptides 511 
containing SϕxK and S/TP motifs from sets of phosphopeptides reduced in the absence of 512 
Shield-1 using Weblogo (http://weblogo.berkeley.edu)67. 513 
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Data availability 514 
The data supporting the results of this study are available within the paper and its 515 
Supplementary Information and Supplementary Data. Sequences of oligonucleotides and 516 
plasmids generated for this study are available from the corresponding author upon request.  517 
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Figure legends 680 
Fig. 1 | Conditional destabilization identified P. falciparum CRK4 as essential for 681 
asexual blood-stage development. a, Schematic of the P. falciparum blood-stage cycle 682 
indicating peak transcript times of kinases targeted with a destabilization domain; purple, 683 
approximate onset of DNA replication; blue, approximate duration of schizogony. b, Single 684 
crossover 3’ replacement strategy to fuse candidate kinases with a hemagglutinin (HA) and a 685 
destabilization domain (DD) tag, which destabilizes kinases in absence of Shield-1. Note, 686 
PKAc, ABCk2, and PF3D7_0420100 were refractory to HA-DD fusion. c, Effect of 687 
conditional kinase destabilization on parasite growth over two cycles (± SD); PMR, parasite 688 
multiplication rate. d, Western blots demonstrate conditional destabilization of PfCRK4 in 689 
two genetic backgrounds; the level of knockdown is indicated below; H3, histone H3. 690 
Fig. 2 | Nuclear localized PfCRK4 is essential for trophozoite-to-schizont transition and 691 
DNA replication. a, Domain structure of PfCRK4; blue, kinase domain; yellow, kinase 692 
domain insertions relative to human CDK2; red, predicted nuclear localization signal (NLS); 693 
asterisk, active site residues; numbers, first and last amino acid (AA). b, Immunofluorescence 694 
detection of PfCRK4-HA-DD in blood stage parasites (representative of three biological 695 
replicates). c, Light microscopy of May-Grünwald-Giemsa-stained PfCRK4-depleted 696 
parasites (D10 parent, representative of two biological replicates and results with P2G12-697 
PfCRK4-HA-DD). d, Ultrastructure of PfCRK4-depleted parasites (D10 parent, 698 
representative of n ≥ 25 cells per condition); arrowhead, spindle pole body; n, nucleus; Rh, 699 
rhoptry. e, Nuclear development in PfCRK4-depleted parasites (D10 parent, representative of 700 
three biological replicates and results with P2G12-PfCRK4-HA-DD). f, Immunofluorescence 701 
detection of spindle structures in PfCRK4-depleted parasites (P2G12 parent, representative of 702 
two biological replicates). g, Quantification of centriolar plaques by immunofluorescence in 703 
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PfCRK4-depleted parasites (D10 parent; p-value, Chi-Square test; representative of two 704 
biological replicates and results with P2G12-PfCRK4-HA-DD). h, DNA content of PfCRK4-705 
depleted parasites from both parental lines; mean ± SD of triplicates (representative of three 706 
biological replicates); ring stage DNA content defined as 1 C. i, Proliferation of parasites 707 
when PfCRK4 was re-stabilized from 38 hpi or 48 hpi of the first cycle onwards, mean ± SD 708 
(representative of two biological replicates and results with P2G12-PfCRK4-HA-DD). 709 
Fig. 3 | PfCRK4 regulates S phase. a, Schematic illustrating the sampling time points for 710 
phosphoproteomic profiling. b, Differential phosphorylation in D10-PfCRK4-HA-DD 711 
parasites [–] Shield-1 relative to [+] Shield-1; 29 hpi in duplicate, 37 hpi in triplicate; p-712 
values by Student`s t-test; grey-shaded regions indicate >2-fold changes in phosphorylation 713 
and p-values of <0.05, number of peptides and respective proteins are indicated. c, GO term 714 
enrichment analysis of proteins with ≥2-fold reduced phosphorylation (p-values <0.05); p-715 
values, Modified Fisher’s Exact Test. Box: P. falciparum homologues of S. cerevisiae factors 716 
required for origin of replication activation in vitro with reduced phosphorylation at 37 hpi in 717 
PfCRK4-depleted parasites; Pol, DNA polymerase; MCM, mini chromosome maintenance 718 
complex; TOP2, topoisomerase 2; RPA, replication protein A; ORC, origin recognition 719 
complex. d, Percentage of shared GO terms of proteins with ≥2-fold reduced phosphorylation 720 
(p-values <0.05) upon PfCRK4-depletion and of substrate sets of human and S. cerevisiae 721 
(Sc) kinases. 722 
Fig. 4 | PfCRK4 is essential throughout schizogony and critical for transmission. a, DNA 723 
content analysis of D10-PfCRK4-HA-DD parasites when PfCRK4 was present or depleted 724 
from 32 hpi, or 36 hpi onwards; 1 C, ring stage DNA content; asterisks, time of Shield-1 725 
removal (representative of two biological replicates and results with P2G12-PfCRK4-HA-726 
DD). Note, second cycle ring-stage parasites re-appear at 48 hpi when PfCRK4 is present. b, 727 
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DAPI-stained nuclei of parasites from Fig. 4a (representative of n ≥ 70 cells per condition). c, 728 
Proliferation of cultures from Fig. 4a, mean ± SD of triplicates. d, Immunofluorescence 729 
detects PfCRK4-HA-DD in gametocytes (P2G12 parent, representative of two biological 730 
replicates). e, Depletion of PfCRK4 during gametocytogenesis diminished oocyst numbers on 731 
An. gambiae female midguts; bars, mean oocyst numbers; ns, not significant; **, p≤ 0.01 732 
(Kruskal-Wallis test). f, Ultrastructure of mosquito-stage parasites from infections with 733 
PfCRK4-depleted gametocytes (P2G12 parent, representative of ≥ ten cells from independent 734 
infection experiments); n, nucleus; ER, endoplasmic reticulum; m, mitochondria; c, capsule. 735 
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